 |
|
Breaking News on Contract Research, Manufacturing & Clinical Trials |
Product innovations > Supplier info center
Azopharma Contract Pharmaceutical Services
Azopharma provides full product development and stand-alone services for the pharmaceutical, biotech and medical device industries. From preclinical to late phase development projects, Azopharma excels at meeting project deadlines while maintaining industry leading quality standards.
Our product development services include:
- Preclinical Services
- Synthetic Services
- Characterization Services
- Preformulation Services
- Formulations Development
- Methods Development & Validation
- Quality Control Testing
- Stability Services
- Clinical Trial Material Manufacturing
- Phase I ExpressTM Services
- Cytotoxic & Potent Compounds
- Respiratory Development Services
- Regulatory Consulting
- Bioanalytical Services
- Drug Delivery Technologies
- Human Clinical
Our goal at Azopharma is to help maximize your financial resources by accelerating your timelines. Our proprietary Phase I Express process is designed to accelerate your drug development by leveraging our ability to manage the execution of multiple projects along parallel timelines.
Phase I Express begins with the synthesis of your NCE followed by its characterization, preformulation development and qualification of the necessary analytical techniques, assuring proper identification, quality and purity.
Azopharma provides formulation services in a variety of dosage forms and in support of preclinical and clinical studies. Starting with Phase I, we can manufacture your clinical trial material as well as conduct the clinical trials, including analytical support. Concurrently, we can provide CMC analytical services including stability studies.
Finally, Azopharma provides a variety of specialty and stand-alone services to support your product development efforts. We specialize in handling cytotoxic and potent compounds and have vigorous controls to insure safe and proper handling. Other specialty services include respiratory services for MDIs and DPIs and drug delivery technology for customized release profiles and poorly soluble drugs.
Related news headlines to Azopharma
Contract manufacturing news in brief
24-Jan-2008 - KBI Biopharma, Helix BioMedix and Azopharma have all recently announced new contract manufacturing news.
APIcross goes solo in drug delivery
19-Nov-2007 - Contract pharmaceutical development company Azopharma has carved out its drug delivery segment into a new company, APIcross Drug Delivery Technologies.
Gateway Chemical Technology revamped after acquisition
26-Sep-2006 - Chemir Analytical Services, the new owner of Gateway Chemical Technology, has renamed the custom chemical analysis business IQsynthesis in a revamp effort.
Featured Suppliers
Related sites
All Decision News Media Sites
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Drug Discovery | Laboratory Equipment | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2008 - Decision News Media SAS - All right reserved.
